Ocuphire Eyes Phase III Path For APX3330 After Mixed Trial Results

 
• By Alaric DeArment
  
Ocuphire announed topline results from its Phase II ZETA-1 trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D